Recruitment is officially OPEN for our Phase 1 clinical trial of NeuCaVis in Ottawa!
We are excited to partner with the @HeartInstitute and @bchowmd to conduct this trial.
If you are interested in participating, visit https://t.co/u3MFd7sv4t
We are thrilled to announce that the first patients have been dosed in our Phase 1 clinical trial of NeuCaVis™ at the @HeartInstitute!
Read the full release: https://t.co/AVd3pDTBu3